Hierarchy of Baby-Linked Immunogenetic Risk Factors in the Vertical Transmission of Hepatitis C Virus

Mother-to-infant transmission of Hepatitis C Virus (HCV) represents the major cause of pediatric HCV infection today. Immunogenetic influence has been poorly investigated and mainly confined to HLA-class II serological polymorphisms. Among 290 parities, 135 from Pavia and 155 from Bergamo, of HCV-RNA-infected Italian women, 21 babies (7.24%) were HCV-RNA positive at birth and steadily positive over 20 months of life. All the 21 infected babies and 44 randomly selected uninfected ones, born to HCV-RNA+ mothers but steadily negative for HCV-RNA during a follow-up of 2 years, and their mothers were investigated for HLA-G, -C, -DRB1, -DQA1 and -DQB1 genomic polymorphisms. Among the different covariates, HLA-Cw*07, -G*010401, -DRB1*0701, -DRB1*1401 and homozigosity for HLA-G 14bp deletion can be considered as risk factors for HCV vertical transmission. On the contrary, protection was conferred by the HLA-DQB1*06, -G*0105N, -Cw*0602, DRB1*1104 and -DRB1*1302 alleles. Our initial question was: has the immunogenetic profile any role in the protection of the fetus growing in an infected milieu and, if so, is it independent from the other non-immunogenetic parameters? The answer to both questions should be yes.

[1]  O. Christiansen,et al.  HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms , 2004, Immunogenetics.

[2]  Z. Husain,et al.  HLA-Cw7 Zygosity Affects the Size of a Subset of CD158b+ Natural Killer Cells , 2004, Journal of Clinical Immunology.

[3]  C. Ober,et al.  Variation in the HLA-G promoter region influences miscarriage rates. , 2003, American journal of human genetics.

[4]  T. Hviid,et al.  HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels , 2003, Immunogenetics.

[5]  P. Simmonds,et al.  A genetic analysis of hepatitis C virus transmission between injection drug users. , 2002, The Journal of infectious diseases.

[6]  M. Goldman.  Clinical course of hepatitis C virus during the first decade of infection: Cohort studyH.E. Harris, M.E. Ramsay, N. Andrews, et al for the HCV National Register Steering Group. BMJ 324:1–5, 2002 , 2002 .

[7]  F. Ansaldi,et al.  Mother‐to‐infant transmission of hepatitis C virus: Rate of infection and assessment of viral load and IgM anti‐HCV as risk factors * , 2002, Journal of medical virology.

[8]  G. Ancora,et al.  HLA DR13 and HCV Vertical Infection , 2002, Pediatric Research.

[9]  D. Prati,et al.  An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy , 2002, British journal of haematology.

[10]  C. Lombardo,et al.  B and C hepatitis viruses, HLA-DQ1 and -DR3 alleles and autoimmunity in patients with hepatocellular carcinoma. , 2002, Journal of hepatology.

[11]  M. Memon,et al.  Hepatitis C: an epidemiological review , 2002, Journal of viral hepatitis.

[12]  G. Zuin,et al.  Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. , 2002, The Journal of infectious diseases.

[13]  N. Andrews,et al.  Clinical course of hepatitis C virus during the first decade of infection: cohort study , 2002, BMJ : British Medical Journal.

[14]  B. Durupınar,et al.  Decreased Frequency of the HLA-DRB1*11 Allele in Patients with Chronic Hepatitis C Virus Infection , 2002, Journal of Virology.

[15]  A. Francavilla,et al.  High rate of spontaneous viral clearance in a cohort of vertically infected hepatitis C virus infants: what lies behind? , 2001, Journal of hepatology.

[16]  A. Francavilla,et al.  Vertical Transmission of Hepatitis C Virus in a Cohort of 2,447 HIV-Seronegative Pregnant Women: A 24-Month Prospective Study , 2001, Journal of pediatric gastroenterology and nutrition.

[17]  P. Bouteiller.  Molécules HLA, immunité et gestation , 2001 .

[18]  M. Mondelli,et al.  Hepatitis C virus genotypes and risk of cirrhosis in southern Italy. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Satsangi,et al.  Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection , 2001, Journal of viral hepatitis.

[20]  Eliseo Minola,et al.  Amniocentesis as a possible risk factor for mother‐to‐infant transmission of hepatitis C virus , 2001, Hepatology.

[21]  C. Oudejans,et al.  HLA-G expression in trophoblast cells circulating in maternal peripheral blood during early pregnancy. , 2001, American journal of obstetrics and gynecology.

[22]  A. Blaschitz,et al.  HLA Class I protein expression in the human placenta. , 2001, Early pregnancy.

[23]  D. Krebs,et al.  Association of soluble HLA-G plasma levels with HLA-G alleles. , 2001, Tissue antigens.

[24]  M. Martinetti,et al.  Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. , 2000, Clinical immunology.

[25]  C. Ober,et al.  HLA-G in reproduction: studies on the maternal-fetal interface. , 2000, Human immunology.

[26]  N. Rouas-Freiss,et al.  HLA-G expression in trophoblast cells is independent of embryonic development. , 2000, Human immunology.

[27]  T. Hoshika,et al.  Prospective reevaluation of risk factors in mother-to-child transmission of hepatitis C virus: high virus load, vaginal delivery, and negative anti-NS4 antibody. , 2000, The Journal of infectious diseases.

[28]  D. Gibb,et al.  Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission , 2000, The Lancet.

[29]  J. Bowen,et al.  Surface expression of HLA-C antigen by human extravillous trophoblast. , 2000, Placenta.

[30]  D. Prati,et al.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women , 2000, Hepatology.

[31]  P. Lionetti,et al.  Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. , 2000, Blood.

[32]  Isabella,et al.  HLA class II favors clearance of HCV infection and progression of the chronic liver damage. , 1999, Journal of hepatology.

[33]  P. Le Bouteiller,et al.  Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism. , 1999, Journal of immunology.

[34]  N. Morling,et al.  Survival of Fetuses and Viruses: Universal Mechanisms of Co‐Existence with an Immunological Potent Host , 1999, American journal of reproductive immunology.

[35]  M. Martinetti,et al.  Human leukocyte antigen class II and III alleles and severity of hepatitis C virus–related chronic liver disease , 1999, Hepatology.

[36]  R. Biassoni,et al.  Natural killer cell-mediated recognition of human trophoblast. , 1999, Seminars in cancer biology.

[37]  M. Martinetti,et al.  Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C. , 1998, Journal of hepatology.

[38]  N. Principi,et al.  Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  J. Dausset,et al.  Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[40]  M. Martinetti,et al.  Critical role of Val/Gly86 HLA-DRB dimorphism in the neonatal resistance or susceptibility to maternal hepatitis C virus infection. , 1997, The Pediatric infectious disease journal.

[41]  M. Momoi,et al.  Loss of Circulating Hepatitis C Virus in Children Who Developed a Persistent Carrier State after Mother-to-Baby Transmission , 1997, Pediatric Research.

[42]  S. Hiby,et al.  Uterine NK Cells and Trophoblast HLA Class I Molecules , 1997, American journal of reproductive immunology.

[43]  E. Halapi,et al.  Role of immunity in maternal—infant HIV‐1 transmission , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[44]  R. Biassoni,et al.  Receptors for HLA class-I molecules in human natural killer cells. , 1996, Annual review of immunology.

[45]  A. Svejgaard,et al.  HLA and disease associations: detecting the strongest association. , 1994, Tissue antigens.

[46]  M. Greenacre,et al.  Correspondence analysis of HLA gene frequency data from 124 population samples. , 1977, American journal of human genetics.